Navigation Links
A New Approach In Treatment Neurogenic Detrusor Overactivity In Children

Many reports have dealt with the outcome of botulinum-a toxin (BTX-A) detrusor injections in patients with neurogenic or nonneurogenic detrusor overactivity. BTX-A detrusor injections have been described in adult// patients with neurogenic detrusor overactivity due to spinal cord injury.

Researchers from Germany were able to carry out the same experiments successfully in children with a neurogenic bladder. After many reports of this “wonder drug,” several questions have arisen, including what this injection treatment means for neurourologic patients in the longer term; whether bladder function changes after repeated BTX-A injections, and whether this procedure has a proper place in the treatment algorithm of young patients with neurogenic bladder. In an extension of their previous studies, the authors, set out o assess the long-term success of treatment with repeated botulinum-A toxin (BTX-A; Botox) injections into the detrusor muscle for neurogenic detrusor overactivity in children.

In their study published in the October issue of Urology, the researchers reviewed the charts of 10 children (average age at first injection 11.2 years) with neurogenic detrusor overactivity who had received at least three BTX-A detrusor injections; four had received five or more injections. The total dose of BTX-A was 85 to 300 U. They measured the urodynamic outcomes 6 months after each injection and compared the results after the first injection with the results after the third and fifth injections (in the children who had five or more injections).

The relative changes - each in comparison with the value before injection therapy - after the first versus the fifth injection were as follows: the reflex volume increased by 81% versus 88%, maximal detrusor pressure decreased by 7% versus 39%, maximal cystometric bladder capacity increased by 88% versus 72%, and bladder compliance showed no change at the 6-month follow-up visit after the first injection a
'"/>




Page: 1 2

Related medicine news :

1. New Dietary Approach To Manage Kidney Stones
2. Approaching through Telemedicine benefits patients
3. Gel Offers A More Targeted Approach
4. New Cost Effective Approach To Promote Sun Protection
5. Treatment Of Brain Aneurysms By A New Non-Surgical Approach
6. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
7. Lazy Eye Can Be Effectively Treated By New Approach
8. Novel Approach to Identify Protein Links with Genetic Disorder
9. NHS To Be Reformed By Using A Hybrid Approach
10. Two-In One Approach To Prevent Incontinence After Prolapse Surgery
11. Women Afflicted With Dry Eyes As They Approach Menopause
Post Your Comments:
(Date:12/2/2008)...ll/ -- Quest Diagnostics Incorporated (NYSE: DGX...ting, information and services, announced that it ...are Conference in New York City today, December 2,...duled to begin at 4:00 p.m. Eastern Time. , ...irm its 2008 guidance for revenue growth of greate...
(Date:12/2/2008)... December 1, 2008, issue of Clinical Cancer Resea...ncer Research, show lapatinib benefits women with ...-negative breast cancer or those who express EGRF ...a misclassification of metastatic breast cancer pa...le from receiving optimal therapy. , Lapatinib,...
(Date:12/2/2008)..., Cost and Energy Efficient Information Infrastruc...re/ -- EMC Corporation (NYSE: EMC ), the world l...ay announced that the Daughters of Charity Health ...spanning the California coast, has consolidated st...ity functions to deliver new online clinical syste...
(Date:12/2/2008)...Emdeon, a leading provider of,revenue and payment...ustry,announced today the launch of an important...are. Emdeon unveiled the U.S. Healthcare Efficienc...blish a national reference for,tracking and measu...ased,system to an electronic one. , "Throu...
Breaking Medicine News(10 mins):Health News:Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference 2Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 3Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 4Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 2Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 4
...ple in a Tamil Nadu village and over 60 doctors ar...tes complications.// A medical technology company,... with the Tirunelveli Medical College at the Ariya...ere. "At present, there is little testing done to...
...have been on an all time high in the United Kingdo...n the rising temperature and pollution levels. //A...iod from 15th to 19th July, the temperatures were ...gen dioxide pollution, which is known to trigger a...
...n their way home after a month-long training in tr...nt in India will surely help improve life in war-t...mastered will help my people in Iraq," Wafa Esmaee...from Bangalore, where she was among 43 Iraqis who ...
...n developed by Georgia Tech researchers to decode ...s with other cells and reacts //to a broad spectru...ld help to better create drugs that are capable of...g human diseases. Most sophisticated tools curren...
Other Medicine News:Health News:Villagers in Tamil Nadu Take Part in Diabetes Pilot Project 2Health News:Sensor Images Show Soaring Temperature and Pollution Levels in UK 2Health News:Yoga and Meditation Comes in Aid of Iraqis to Rid of Trauma 2Health News:Yoga and Meditation Comes in Aid of Iraqis to Rid of Trauma 3Health News:Cell Behavior Better Understood with Nano Probe 2Health News:Cell Behavior Better Understood with Nano Probe 3
(Date:11/26/2008)...26 Children whose eyes ...tly increased risk of developing mental illness by... Clinic study published this month in Pediatrics ,...ediatrics. , , The retrospective study exam...bismus (misaligned eyes) and compared them with re...
(Date:11/25/2008)...5 Kleinert Kutz and Un...e fifth U.S. hand transplant on Messina, New York ...ish Hospital Hand Care Center on Monday, November ...d was completed shortly after 9 p.m. in a record n....com/cgi-bin/prnh/20081125/DC48555-a ) , (Photo...
(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 1Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 2Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 3Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 1Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 1New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 3New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 4New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 5Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 1Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 2Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 3Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 4
...s.--(BUSINESS WIRE)--Apr 12, 2007 - CombinatoRx,I...osters related,to its oncology research efforts wi...American Association for Cancer Research,April 14...ng of Targeted Chemical Combinations for,Cancer Th...resented,on Sunday, April 15, 1-5pm PT and "Synerg...
...ion pyridopyrazine-urea derivative compound series... be valuable for,cancer treatment, QUEBEC, April 1...Inc. , a global, pure play biopharmaceutical compa...y presented an abstract,outlining first in vitro d...lectivity for PI3K inhibition, at the American,Ass...
Other Medicine Technology:CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 2CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 3AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3
These precision 4mL PYREX volumetric pipets are manufactured and calibrated "To Contain" (TC - bottom line) and "To Deliver" (TD - top line) to specifications for Class A volumetric ware. Pipets are
The new Finnpipette Focus from Thermo Labsystems was designed specifically to combine ergonomics with uncompromising performance. The new interchangeable handle plate offers a custom fit for differe
Inquire
A fixed pipette is ideal for repeated pipetting of a single volume. Fixed volume FInnpipettes offer the same features and advantages as other Finnpipette Digital pipettes: New, streamlined design, S
Medicine Products: